Follow the people · Insider
Andrew Guggenhime
Andrew Guggenhime files insider transactions with the SEC as a president and cfo of Vaxcyte (PCVX). We hold 3 disclosed purchases and sales filed since 13 January 2006, 3 of them in the last 90 days.
- Files forPCVX
- Disclosed buys and sells3 in all, 3 in the last 90 days
- Last disclosure2 September 2026
Positions held
7 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 April 2021 — 2 September 2026President and CFO · Vaxcyte (PCVX)187 Form 4 lines · source: SEC Form 4
- Filed 20 December 2021 — 20 February 2026Director · Caribou Biosciences (CRBU)6 Form 4 lines · source: SEC Form 4
- Filed 24 May 2021 — 18 May 2022Director · Metacrine (MTCR)2 Form 4 lines · source: SEC Form 4
- Filed 2 October 2014 — 20 February 2020CFO · Dermira (DERM)73 Form 4 lines · source: SEC Form 4
- Filed 23 January 2009 — 21 April 2010SVP & CFO · Facet Biotech (FACT)13 Form 4 lines · source: SEC Form 4
- Filed 3 April 2006 — 18 December 2008SVP & Chief Financial Officer · Pdl Biopharma (PDLI)8 Form 4 lines · source: SEC Form 4
- Filed 29 July 2005 — 29 July 2005Chief Financial Officer · Neoforma (NEOF)1 Form 4 line · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 1,273 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- had shares withheld for tax on 1,432 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 10,000 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 6,956 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 3,044 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- exercised options over 10,000 shares of Vaxcyte (a derivative holding)SEC Form 45 August 2026Stock Option (right to buy) · traded 3 August 2026 · filed 5 August 2026
- exercised options over 10,000 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 6 July 2026 · filed 6 July 2026
- ▼ sold on the open market 7,913 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 6 July 2026 · filed 6 July 2026
- ▼ sold on the open market 2,087 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 6 July 2026 · filed 6 July 2026
- exercised options over 10,000 shares of Vaxcyte (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 6 July 2026 · filed 6 July 2026
- exercised options over 10,000 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- ▼ sold on the open market 10,000 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- exercised options over 10,000 shares of Vaxcyte (a derivative holding)SEC Form 418 June 2026Stock Option (right to buy) · traded 18 June 2026 · filed 18 June 2026
- had shares withheld for tax on 1,021 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- had shares withheld for tax on 1,021 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- was granted 44,864 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 898 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 1,009 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- was granted 74,993 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 74,993 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 44,864 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 898 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 1,009 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- was granted 45,000 shares of Caribou Biosciences (a derivative holding)SEC Form 420 February 2026Option to purchase Common Stock · traded 20 February 2026 · filed 20 February 2026
- was granted 45,000 shares of Caribou Biosciences (a derivative holding)SEC Form 420 February 2026Option to purchase Common Stock · traded 20 February 2026 · filed 20 February 2026
- gave away 61,850 shares of VaxcyteSEC Form 416 January 2026Common Stock · traded 14 January 2026 · filed 16 January 2026
- gave away 61,850 shares of VaxcyteSEC Form 416 January 2026Common Stock · traded 14 January 2026 · filed 16 January 2026
- gave away 61,850 shares of VaxcyteSEC Form 416 January 2026Common Stock · traded 14 January 2026 · filed 16 January 2026
- gave away 61,850 shares of VaxcyteSEC Form 416 January 2026Common Stock · traded 14 January 2026 · filed 16 January 2026
- had shares withheld for tax on 2,890 shares of VaxcyteSEC Form 410 September 2025Common Stock · traded 8 September 2025 · filed 10 September 2025
- had shares withheld for tax on 1,270 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 2,381 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 1,429 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 4,777 shares of Vaxcyte (a derivative holding)SEC Form 49 April 2025Stock Option (right to buy) · traded 7 April 2025 · filed 9 April 2025
- exercised options over 4,777 shares of VaxcyteSEC Form 49 April 2025Common Stock · traded 7 April 2025 · filed 9 April 2025
- was granted 75,991 shares of Vaxcyte (a derivative holding)SEC Form 43 March 2025Stock Option (right to buy) · traded 27 February 2025 · filed 3 March 2025
- was granted 22,761 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- had shares withheld for tax on 1,270 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 28 February 2025 · filed 3 March 2025
- had shares withheld for tax on 3,809 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- was granted 40,500 shares of Caribou Biosciences (a derivative holding)SEC Form 421 February 2025Option to purchase Common Stock · traded 20 February 2025 · filed 21 February 2025
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 419 February 2025Stock Option (right to buy) · traded 18 February 2025 · filed 19 February 2025
- exercised options over 8,000 shares of VaxcyteSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- ▼ sold on the open market 6,182 shares of VaxcyteSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- ▼ sold on the open market 1,818 shares of VaxcyteSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 January 2025Stock Option (right to buy) · traded 21 January 2025 · filed 22 January 2025
- exercised options over 8,000 shares of VaxcyteSEC Form 422 January 2025Common Stock · traded 21 January 2025 · filed 22 January 2025
- ▼ sold on the open market 5,318 shares of VaxcyteSEC Form 422 January 2025Common Stock · traded 21 January 2025 · filed 22 January 2025
- ▼ sold on the open market 1,999 shares of VaxcyteSEC Form 422 January 2025Common Stock · traded 21 January 2025 · filed 22 January 2025
- ▼ sold on the open market 683 shares of VaxcyteSEC Form 422 January 2025Common Stock · traded 21 January 2025 · filed 22 January 2025
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 419 December 2024Stock Option (right to buy) · traded 18 December 2024 · filed 19 December 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 419 December 2024Common Stock · traded 18 December 2024 · filed 19 December 2024
- ▼ sold on the open market 1,190 shares of VaxcyteSEC Form 419 December 2024Common Stock · traded 18 December 2024 · filed 19 December 2024
- ▼ sold on the open market 3,373 shares of VaxcyteSEC Form 419 December 2024Common Stock · traded 18 December 2024 · filed 19 December 2024
- ▼ sold on the open market 3,157 shares of VaxcyteSEC Form 419 December 2024Common Stock · traded 18 December 2024 · filed 19 December 2024
- ▼ sold on the open market 280 shares of VaxcyteSEC Form 419 December 2024Common Stock · traded 18 December 2024 · filed 19 December 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 419 November 2024Stock Option (right to buy) · traded 18 November 2024 · filed 19 November 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- ▼ sold on the open market 6,111 shares of VaxcyteSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- ▼ sold on the open market 1,757 shares of VaxcyteSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- ▼ sold on the open market 132 shares of VaxcyteSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- was granted 87,481 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Performance Stock Option (right to buy) · traded 7 November 2024 · filed 8 November 2024
- was granted 35,661 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Performance Restricted Stock Units · traded 7 November 2024 · filed 8 November 2024
- exercised options over 19,108 shares of Vaxcyte (a derivative holding)SEC Form 428 October 2024Stock Option (right to buy) · traded 25 October 2024 · filed 28 October 2024
- exercised options over 19,108 shares of VaxcyteSEC Form 428 October 2024Common Stock · traded 25 October 2024 · filed 28 October 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 October 2024Stock Option (right to buy) · traded 18 October 2024 · filed 22 October 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 October 2024Stock Option (right to buy) · traded 18 October 2024 · filed 22 October 2024
- exercised options over 12,000 shares of Vaxcyte (a derivative holding)SEC Form 422 October 2024Stock Option (right to buy) · traded 18 October 2024 · filed 22 October 2024
- exercised options over 14,000 shares of Vaxcyte (a derivative holding)SEC Form 422 October 2024Stock Option (right to buy) · traded 18 October 2024 · filed 22 October 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 422 October 2024Common Stock · traded 18 October 2024 · filed 22 October 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 422 October 2024Common Stock · traded 18 October 2024 · filed 22 October 2024
- exercised options over 12,000 shares of VaxcyteSEC Form 422 October 2024Common Stock · traded 18 October 2024 · filed 22 October 2024
- exercised options over 14,000 shares of VaxcyteSEC Form 422 October 2024Common Stock · traded 18 October 2024 · filed 22 October 2024
- ▼ sold on the open market 36,114 shares of VaxcyteSEC Form 422 October 2024Common Stock · traded 18 October 2024 · filed 22 October 2024
- ▼ sold on the open market 5,886 shares of VaxcyteSEC Form 422 October 2024Common Stock · traded 18 October 2024 · filed 22 October 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 419 September 2024Stock Option (right to buy) · traded 18 September 2024 · filed 19 September 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 419 September 2024Common Stock · traded 18 September 2024 · filed 19 September 2024
- ▼ sold on the open market 5,485 shares of VaxcyteSEC Form 419 September 2024Common Stock · traded 18 September 2024 · filed 19 September 2024
- ▼ sold on the open market 1,686 shares of VaxcyteSEC Form 419 September 2024Common Stock · traded 18 September 2024 · filed 19 September 2024
- ▼ sold on the open market 829 shares of VaxcyteSEC Form 419 September 2024Common Stock · traded 18 September 2024 · filed 19 September 2024
- had shares withheld for tax on 6,337 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 420 August 2024Stock Option (right to buy) · traded 19 August 2024 · filed 20 August 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 420 August 2024Common Stock · traded 19 August 2024 · filed 20 August 2024
- ▼ sold on the open market 4,994 shares of VaxcyteSEC Form 420 August 2024Common Stock · traded 19 August 2024 · filed 20 August 2024
- ▼ sold on the open market 3,006 shares of VaxcyteSEC Form 420 August 2024Common Stock · traded 19 August 2024 · filed 20 August 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 July 2024Stock Option (right to buy) · traded 18 July 2024 · filed 22 July 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 422 July 2024Common Stock · traded 18 July 2024 · filed 22 July 2024
- ▼ sold on the open market 3,095 shares of VaxcyteSEC Form 422 July 2024Common Stock · traded 18 July 2024 · filed 22 July 2024
- ▼ sold on the open market 2,500 shares of VaxcyteSEC Form 422 July 2024Common Stock · traded 18 July 2024 · filed 22 July 2024
- ▼ sold on the open market 1,479 shares of VaxcyteSEC Form 422 July 2024Common Stock · traded 18 July 2024 · filed 22 July 2024
- ▼ sold on the open market 926 shares of VaxcyteSEC Form 422 July 2024Common Stock · traded 18 July 2024 · filed 22 July 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 420 June 2024Stock Option (right to buy) · traded 18 June 2024 · filed 20 June 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
- ▼ sold on the open market 7,652 shares of VaxcyteSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
- ▼ sold on the open market 348 shares of VaxcyteSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 May 2024Stock Option (right to buy) · traded 20 May 2024 · filed 22 May 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 422 May 2024Common Stock · traded 20 May 2024 · filed 22 May 2024
- ▼ sold on the open market 3,544 shares of VaxcyteSEC Form 422 May 2024Common Stock · traded 20 May 2024 · filed 22 May 2024
- ▼ sold on the open market 4,456 shares of VaxcyteSEC Form 422 May 2024Common Stock · traded 20 May 2024 · filed 22 May 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 April 2024Stock Option (right to buy) · traded 18 April 2024 · filed 22 April 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 422 April 2024Common Stock · traded 18 April 2024 · filed 22 April 2024
- ▼ sold on the open market 7,624 shares of VaxcyteSEC Form 422 April 2024Common Stock · traded 18 April 2024 · filed 22 April 2024
- ▼ sold on the open market 376 shares of VaxcyteSEC Form 422 April 2024Common Stock · traded 18 April 2024 · filed 22 April 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 420 March 2024Stock Option (right to buy) · traded 18 March 2024 · filed 20 March 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 420 March 2024Common Stock · traded 18 March 2024 · filed 20 March 2024
- ▼ sold on the open market 7,764 shares of VaxcyteSEC Form 420 March 2024Common Stock · traded 18 March 2024 · filed 20 March 2024
- ▼ sold on the open market 236 shares of VaxcyteSEC Form 420 March 2024Common Stock · traded 18 March 2024 · filed 20 March 2024
- was granted 90,000 shares of Vaxcyte (a derivative holding)SEC Form 44 March 2024Stock Option (right to buy) · traded 29 February 2024 · filed 4 March 2024
- was granted 20,000 shares of VaxcyteSEC Form 44 March 2024Common Stock · traded 29 February 2024 · filed 4 March 2024
- had shares withheld for tax on 3,795 shares of VaxcyteSEC Form 44 March 2024Common Stock · traded 2 March 2024 · filed 4 March 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 422 February 2024Stock Option (right to buy) · traded 20 February 2024 · filed 22 February 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 422 February 2024Common Stock · traded 20 February 2024 · filed 22 February 2024
- ▼ sold on the open market 4,909 shares of VaxcyteSEC Form 422 February 2024Common Stock · traded 20 February 2024 · filed 22 February 2024
- ▼ sold on the open market 2,751 shares of VaxcyteSEC Form 422 February 2024Common Stock · traded 20 February 2024 · filed 22 February 2024
- ▼ sold on the open market 340 shares of VaxcyteSEC Form 422 February 2024Common Stock · traded 20 February 2024 · filed 22 February 2024
- was granted 39,500 shares of Caribou Biosciences (a derivative holding)SEC Form 422 February 2024Option to purchase Common Stock · traded 20 February 2024 · filed 22 February 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 419 January 2024Stock Option (right to buy) · traded 18 January 2024 · filed 19 January 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 419 January 2024Common Stock · traded 18 January 2024 · filed 19 January 2024
- ▼ sold on the open market 4,387 shares of VaxcyteSEC Form 419 January 2024Common Stock · traded 18 January 2024 · filed 19 January 2024
- ▼ sold on the open market 3,127 shares of VaxcyteSEC Form 419 January 2024Common Stock · traded 18 January 2024 · filed 19 January 2024
- ▼ sold on the open market 463 shares of VaxcyteSEC Form 419 January 2024Common Stock · traded 18 January 2024 · filed 19 January 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.